GR3033636T3 - Dna sequence and encoded mammary-specific breast cancer protein - Google Patents

Dna sequence and encoded mammary-specific breast cancer protein

Info

Publication number
GR3033636T3
GR3033636T3 GR20000401323T GR20000401323T GR3033636T3 GR 3033636 T3 GR3033636 T3 GR 3033636T3 GR 20000401323 T GR20000401323 T GR 20000401323T GR 20000401323 T GR20000401323 T GR 20000401323T GR 3033636 T3 GR3033636 T3 GR 3033636T3
Authority
GR
Greece
Prior art keywords
breast cancer
dna sequence
mammaglobin
cancer protein
specific breast
Prior art date
Application number
GR20000401323T
Other languages
English (en)
Inventor
Mark A Watson
Timothy P Fleming
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of GR3033636T3 publication Critical patent/GR3033636T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GR20000401323T 1995-05-31 2000-06-08 Dna sequence and encoded mammary-specific breast cancer protein GR3033636T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/455,896 US5668267A (en) 1995-05-31 1995-05-31 Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
PCT/US1996/008235 WO1996038463A1 (en) 1995-05-31 1996-05-31 Dna sequence and encoded mammary-specific breast cancer protein

Publications (1)

Publication Number Publication Date
GR3033636T3 true GR3033636T3 (en) 2000-10-31

Family

ID=23810680

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20000401323T GR3033636T3 (en) 1995-05-31 2000-06-08 Dna sequence and encoded mammary-specific breast cancer protein

Country Status (22)

Country Link
US (5) US5668267A (el)
EP (1) EP0833834B1 (el)
JP (2) JP3949165B2 (el)
KR (1) KR19990022122A (el)
CN (1) CN1279051C (el)
AT (1) ATE190313T1 (el)
AU (1) AU698823B2 (el)
BR (1) BR9609270A (el)
CA (2) CA2741641C (el)
CZ (1) CZ378397A3 (el)
DE (1) DE69607001T2 (el)
DK (1) DK0833834T3 (el)
EA (1) EA001398B1 (el)
ES (1) ES2145451T3 (el)
GR (1) GR3033636T3 (el)
HU (1) HUP9900873A3 (el)
NO (1) NO975508L (el)
NZ (1) NZ309445A (el)
PL (1) PL323632A1 (el)
PT (1) PT833834E (el)
TR (1) TR199701462T1 (el)
WO (1) WO1996038463A1 (el)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566072B1 (en) 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US6423496B1 (en) 1996-01-11 2002-07-23 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6174992B1 (en) 1997-03-21 2001-01-16 Human Genome Sciences, Inc. Human endometrial specific steroid-binding factor I, II and III
EP0896614A4 (en) * 1996-03-21 1999-05-12 Human Genome Sciences Inc HUMANE, ENDOMETRIUM-SPECIFIC STEROID-BINDING FACTORS I, II AND III
US20030044859A1 (en) * 1996-08-19 2003-03-06 Henslee Jerry G. Reagents and methods useful for detecting diseases of the breast
US6379671B1 (en) * 1996-08-19 2002-04-30 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP0856010A1 (en) * 1996-08-19 1998-08-05 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast
US6770435B1 (en) 1996-08-19 2004-08-03 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US6552164B1 (en) 1996-08-19 2003-04-22 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US7282207B1 (en) 1996-08-19 2007-10-16 Abbott Laboratories Reagents and methods useful for detecting diseases of the reproductive tissues
EP0941328A1 (en) * 1996-11-12 1999-09-15 Incyte Pharmaceuticals, Inc. Human breast tumor-specific proteins
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
DE69830169T2 (de) 1997-06-09 2006-02-16 Smithkline Beecham Corp. Nachweis und behandlung von krebs
JP2003521216A (ja) * 1997-08-05 2003-07-15 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ９０個のヒト分泌タンパク質
JP2001520015A (ja) * 1997-10-16 2001-10-30 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒト・マンモグロビンホモログ
WO1999025877A1 (en) * 1997-11-18 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
EP1042506A1 (en) * 1997-12-26 2000-10-11 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999037775A2 (en) * 1998-01-26 1999-07-29 Genquest, Inc. Compositions and methods for detecting and treating breast cancer
DE19813839A1 (de) * 1998-03-20 1999-09-23 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Brusttumorgewebe
US6737040B1 (en) 1998-08-04 2004-05-18 Diadexus, Inc. Method and antibody for imaging breast cancer
JP3422776B2 (ja) * 1998-08-04 2003-06-30 ダイアデクスアス・インコーポレーテッド 乳癌を診断、監視、病期決定、造影及び治療する新規な方法
US6730477B1 (en) * 1998-08-04 2004-05-04 Diadexus, Inc. Method of diagnosing, monitoring and staging breast cancer
JP2002527723A (ja) * 1998-10-02 2002-08-27 ダイアデクスアス・インコーポレーテッド 婦人科癌を診断、監視、病期分類、イメージング及び治療する新規な方法
US7014996B1 (en) 1998-10-02 2006-03-21 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6471660B1 (en) 1999-01-21 2002-10-29 Chandice Covington Method and apparatus for measuring factors in mammary fluids
AU5449600A (en) * 1999-05-28 2000-12-18 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
US6416956B1 (en) 1999-08-13 2002-07-09 George Washington University Transcription factor, BP1
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
CA2392510A1 (en) * 1999-11-30 2001-06-07 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
EP1399584A2 (en) * 2000-10-11 2004-03-24 Avalon Pharmaceuticals Cancer-linked genes as targets for chemotherapy
DK1889630T3 (da) 2000-10-18 2012-03-05 Glaxosmithkline Biolog Sa Vacciner omfattende MAGE-antigen koblet til protein D-fragment
GB0109297D0 (en) 2001-04-12 2001-05-30 Glaxosmithkline Biolog Sa Vaccine
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) * 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
WO2003076896A2 (en) * 2002-03-06 2003-09-18 Johns Hopkins University Use of biomarkers to detect breast cancer
US20050186577A1 (en) * 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7981616B2 (en) * 2004-02-27 2011-07-19 Musc Foundation For Research Development Enhanced detection of RNA using a panel of truncated gene-specific primers for reverse transcription
BRPI0616090A2 (pt) 2005-09-19 2011-06-07 Veridex Llc métodos e materiais para identificação da origem de um carcinoma de origem primária desconhecida
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US20120251509A1 (en) * 2009-10-22 2012-10-04 Waldman Scott A Cell-based anti-cancer compositions and methods of making and using the same
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
WO2021172923A1 (ko) * 2020-02-27 2021-09-02 ㈜베르티스 암의 진단용 조성물
KR102433983B1 (ko) * 2020-02-27 2022-08-23 주식회사 베르티스 암의 진단용 조성물
KR102499678B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물
KR102499664B1 (ko) * 2020-02-27 2023-02-15 주식회사 베르티스 암의 진단용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298399A (en) * 1990-08-10 1994-03-29 Sapporo Breweries Limited Gene and process for producing a thermostable urease
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein

Also Published As

Publication number Publication date
BR9609270A (pt) 1999-05-11
JP3949165B2 (ja) 2007-07-25
EA001398B1 (ru) 2001-02-26
DE69607001T2 (de) 2000-11-02
HUP9900873A2 (hu) 1999-07-28
EP0833834B1 (en) 2000-03-08
MX9709364A (es) 1998-08-30
US5668267A (en) 1997-09-16
ATE190313T1 (de) 2000-03-15
KR19990022122A (ko) 1999-03-25
CN1189836A (zh) 1998-08-05
JP2007145855A (ja) 2007-06-14
US5855889A (en) 1999-01-05
WO1996038463A1 (en) 1996-12-05
US5968754A (en) 1999-10-19
NO975508L (no) 1998-03-18
PL323632A1 (en) 1998-04-14
US6677428B1 (en) 2004-01-13
CA2741641A1 (en) 1996-12-05
JP3989528B2 (ja) 2007-10-10
ES2145451T3 (es) 2000-07-01
PT833834E (pt) 2000-08-31
CZ378397A3 (cs) 1998-06-17
DK0833834T3 (da) 2000-07-31
NO975508D0 (no) 1997-11-28
CA2222747C (en) 2011-06-28
JPH11507212A (ja) 1999-06-29
AU698823B2 (en) 1998-11-05
DE69607001D1 (de) 2000-04-13
US6004756A (en) 1999-12-21
TR199701462T1 (xx) 1998-04-21
EP0833834A1 (en) 1998-04-08
EP0833834A4 (en) 1998-06-03
NZ309445A (en) 1999-11-29
CA2741641C (en) 2014-08-05
AU5961696A (en) 1996-12-18
CA2222747A1 (en) 1996-12-05
EA199700447A1 (ru) 1998-08-27
CN1279051C (zh) 2006-10-11
HUP9900873A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
GR3033636T3 (en) Dna sequence and encoded mammary-specific breast cancer protein
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
EP1652931A3 (fr) Adénovirus recombinants, préparation et utilisation pour le traitement et/ou la prévention des cancers
AU2060897A (en) Murine alpha(1,3)fucosyltransferase fuc-tvii, dna encoding the same, method for preparing the same, antibodies recognizing the same, immunoassays for detecting the same, plasmids containing such dna, and cells containing such plasmid
MX9708791A (es) Gen de ataxia-telangiectasia y su organizacion genomica.
AU1316200A (en) Metastatic breast and colon cancer regulated genes
AU2001258316A1 (en) Process for the fermentative preparation of l-threonine
WO2000050588A3 (en) Genes associated with diseases of the colon
MXPA01003240A (es) Mamaglobina, una proteina secretada del cancer mamario especifica de mama.
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
MX9806041A (es) Proteina purificada sr-p70.
WO1994028129A3 (en) Tumour metastasis gene
EA200200319A1 (ru) Белок iren, его получение и использование
HK1118861A1 (en) Genes differentially expressed in breast cancer
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
AU3956399A (en) Iga nephropathy-associated dna
UA30391A (uk) Спосіб лікування колоректального раку
ZA979723B (en) Methods of preventing breast cancer.
AU2002301149A1 (en) Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
WO2001079437A3 (fr) Nouveau polypeptide, facteur humain de transcription de la differentiation cellulaire 14, et polynucleotide codant pour ce polypeptide